⌘K

Login Start Free

Home/Filings/4/0001209191-20-062047

4//SEC Filing

Hunder Naomi 4

Accession 0001209191-20-062047

CIK 0001671858other

View on SEC.gov Company Profile

Filed

Dec 6, 7:00 PM ET

Accepted

Dec 7, 7:51 PM ET

Size

5.4 KB

Accession

0001209191-20-062047

Insider Transaction Report

Form 4

Period: 2020-12-03

Silverback Therapeutics, Inc.SBTX

Chief Medical Officer

Transactions

Award
Stock Option (right to buy)
2020-12-03+231,071→ 231,071 total
Exercise: $21.00Exp: 2030-12-02→ Common Stock (231,071 underlying)

Footnotes (1)

[F1]The shares subject to the option vest in equal monthly installments over the 48 months following December 3, 2020.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Silverback Therapeutics, Inc.

CIK 0001671858

Entity typeother

Related Parties

1

filerCIK 0001832170

Filing Metadata

Form type: 4
Filed: Dec 6, 7:00 PM ET
Accepted: Dec 7, 7:51 PM ET
Size: 5.4 KB

View on SEC.gov